Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000861731 | SCV001002123 | benign | Primary ciliary dyskinesia | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000861731 | SCV002723254 | benign | Primary ciliary dyskinesia | 2017-02-06 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002495220 | SCV002798820 | likely benign | Kartagener syndrome | 2021-07-22 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000861731 | SCV001462495 | uncertain significance | Primary ciliary dyskinesia | 2019-11-11 | no assertion criteria provided | clinical testing |